| PERIOD ENDING | 31-Jan-09 | 2-Feb-08 | 3-Feb-07 | | Total Revenue | 1,064,569 | 969,403 | 911,438 | | Cost of Revenue | 794,080 | 728,649 | 686,722 | | | Gross Profit | 270,489 | 240,754 | 224,716 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 257,822 | 240,744 | 207,889 | | Non Recurring | 9,469 | 11,329 | 1,845 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 3,198 | (11,319) | 14,982 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (9,037) | | Earnings Before Interest And Taxes | 3,198 | (11,319) | 5,945 | | Interest Expense | 18,008 | 19,745 | 19,187 | | Income Before Tax | (14,810) | (31,064) | (13,242) | | Income Tax Expense | 687 | 750 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,497) | (31,814) | (13,242) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (15,497) | (31,814) | (13,242) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,497) | ($31,814) | ($13,242) |
|
0.14% Nasdaq 
0.36%
Income Statement
